A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II)

  1. Kenichi Suzuki
  2. Takashi Yokokawa
  3. Takashi Kawaguchi
  4. Shinya Takada
  5. Shinya Tamaki
  6. Yohei Kawasaki
  7. Takumi Yamaguchi
  8. Kei Koizumi
  9. Takuma Matsumoto
  10. Yukio Sakata
  11. Yuichiro Arakawa
  12. Hideaki Ayuhara
  13. Mari Hosonaga
  14. Masakazu Yamaguchi
  15. Daiki Tsuji
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1038/s41598-024-79781-6
  2. Version published to 10.21203/rs.3.rs-4832452/v1 on Research Square